These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12271805)

  • 1. Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors.
    Morrison AP; Bentall RP; French P; Walford L; Kilcommons A; Knight A; Kreutz M; Lewis SW
    Br J Psychiatry Suppl; 2002 Sep; 43():s78-84. PubMed ID: 12271805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial.
    Morrison AP; French P; Walford L; Lewis SW; Kilcommons A; Green J; Parker S; Bentall RP
    Br J Psychiatry; 2004 Oct; 185():291-7. PubMed ID: 15458988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metacognitive beliefs across the continuum of psychosis: comparisons between patients with psychotic disorders, patients at ultra-high risk and non-patients.
    Morrison AP; French P; Wells A
    Behav Res Ther; 2007 Sep; 45(9):2241-6. PubMed ID: 17316556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core schemas across the continuum of psychosis: a comparison of clinical and non-clinical groups.
    Taylor HE; Stewart SL; Dunn G; Parker S; Fowler D; Morrison AP
    Behav Cogn Psychother; 2014 Nov; 42(6):718-30. PubMed ID: 23920050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal prevention of first psychotic episode through N-acetyl-l-cysteine and integrated preventive psychological intervention in individuals clinically at high risk for psychosis: Protocol of a randomized, placebo-controlled, parallel-group trial.
    Schmidt SJ; Hurlemann R; Schultz J; Wasserthal S; Kloss C; Maier W; Meyer-Lindenberg A; Hellmich M; Muthesius-Digón A; Pantel T; Wiesner PS; Klosterkötter J; Ruhrmann S;
    Early Interv Psychiatry; 2019 Dec; 13(6):1404-1415. PubMed ID: 30784233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-Year Follow-up of Cognitive Behavioral Therapy in Persons at Ultra-High Risk for Developing Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.
    Ising HK; Kraan TC; Rietdijk J; Dragt S; Klaassen RM; Boonstra N; Nieman DH; Willebrands-Mendrik M; van den Berg DP; Linszen DH; Wunderink L; Veling W; Smit F; van der Gaag M
    Schizophr Bull; 2016 Sep; 42(5):1243-52. PubMed ID: 26994397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core Schemas in Youth at Clinical High Risk for Psychosis.
    Stowkowy J; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Heinssen R; Addington J
    Behav Cogn Psychother; 2016 Mar; 44(2):203-13. PubMed ID: 25896713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early detection of psychotic disorders].
    Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
    Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unhelpful metacognitive beliefs in early psychosis are associated with affective symptoms and childhood social adjustment.
    Østefjells T; Melle I; Hagen R; Romm KL; Sönmez N; Andreassen OA; Røssberg JI
    Schizophr Res; 2015 Dec; 169(1-3):280-285. PubMed ID: 26519990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk.
    Morrison AP; French P; Parker S; Roberts M; Stevens H; Bentall RP; Lewis SW
    Schizophr Bull; 2007 May; 33(3):682-7. PubMed ID: 16973786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological factors in people at ultra-high risk of psychosis: comparisons with non-patients and associations with symptoms.
    Morrison AP; French P; Lewis SW; Roberts M; Raja S; Neil ST; Parker S; Green J; Kilcommons A; Walford L; Bentall RP
    Psychol Med; 2006 Oct; 36(10):1395-404. PubMed ID: 16817985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of metacognitive beliefs in the proneness to hallucinations and delusions: an analysis across clinical and non-clinical populations.
    Goldstone E; Farhall J; Thomas N; Ong B
    Br J Clin Psychol; 2013 Sep; 52(3):330-46. PubMed ID: 23865408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled trial of cognitive behaviour therapy versus non-directive reflective listening for young people at ultra high risk of developing psychosis: The detection and evaluation of psychological therapy (DEPTh) trial.
    Stain HJ; Bucci S; Baker AL; Carr V; Emsley R; Halpin S; Lewin T; Schall U; Clarke V; Crittenden K; Startup M
    Schizophr Res; 2016 Oct; 176(2-3):212-219. PubMed ID: 27554197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial.
    Glenthøj LB; Fagerlund B; Randers L; Hjorthøj CR; Wenneberg C; Krakauer K; Vosgerau A; Gluud C; Medalia A; Roberts DL; Nordentoft M
    Trials; 2015 Jan; 16():25. PubMed ID: 25623736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients.
    Gleeson JF; Cotton SM; Alvarez-Jimenez M; Wade D; Gee D; Crisp K; Pearce T; Newman B; Spiliotacopoulos D; Castle D; McGorry PD
    J Clin Psychiatry; 2009 Apr; 70(4):477-86. PubMed ID: 19323964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizotypy and clinical symptoms, cognitive function, and quality of life in individuals with a psychotic disorder.
    Brosey E; Woodward ND
    Schizophr Res; 2015 Aug; 166(1-3):92-7. PubMed ID: 26002072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prevention of psychosis through interventions in the symptomatic prodromal phase, a pragmatic Norwegian Ultra High Risk study.
    Joa I; Gisselgård J; Brønnick K; McGlashan T; Johannessen JO
    BMC Psychiatry; 2015 Apr; 15():89. PubMed ID: 25897797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
    Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
    JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of metacognitive beliefs in determining the impact of anomalous experiences: a comparison of help-seeking and non-help-seeking groups of people experiencing psychotic-like anomalies.
    Brett CM; Johns LC; Peters EP; McGuire PK
    Psychol Med; 2009 Jun; 39(6):939-50. PubMed ID: 19000336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
    Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
    Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.